Last reviewed · How we verify
Acetaminophen Suppositories
At a glance
| Generic name | Acetaminophen Suppositories |
|---|---|
| Also known as | Napa Suppositories |
| Sponsor | Rawalpindi Medical College |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Somnolence
- Erythema
- Irritability
- Pyrexia
- Pain
- Swelling
- Decreased appetite
- Hyperkalaemia
- Delayed graft function
- Anaemia
- Leukopenia
- Lymphocyte count decreased
Key clinical trials
- Effectiveness Of Intravenous Vs Rectal Acetaminophen For Pain Management In Post Operative Neonates (NA)
- Effects of Inhibiting Early Inflammation in Kidney Transplant Patients (PHASE2)
- Improving Post-Operative Pain and Recovery in Gynecologic Surgery (PHASE4)
- Rectal Acetaminophen Use During Oocyte Retrievals to Reduce Post-Operative Opioid Utilization (PHASE4)
- Levobupivacaine and Postoperative Pain Relief (PHASE4)
- Oral and Perioral Herpes Simplex Virus Infection Type I in a Five-month-old Infant: A Case Report
- Is Paracetamol an Effective Treatment for Chronic Moderate Pain in the Newborn After Operative Vaginal Delivery? (PHASE4)
- Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Acetaminophen Suppositories CI brief — competitive landscape report
- Acetaminophen Suppositories updates RSS · CI watch RSS
- Rawalpindi Medical College portfolio CI